Oncology is one of the most exciting and fast-moving therapy areas in healthcare, due to earlier detection of cancer and new treatments both contributing to improved patient outcomes. June’s 2021 ASCO Conference highlighted some of the new trends in the future of oncology management and the EHA Conference has been similarly enlightening. However, with these new opportunities, come new challenges.
At Research Partnership we understand oncology - one in five of the global projects we manage is in this therapy area. We have experience across solid and non-solid tumours and have conducted research from early-stage market understanding through to commercialisation, launch and beyond. We have particular expertise in novel and targeted therapies including PDL1s and other immunotherapies, cell and gene therapies, ADCs, TKIs and hormone therapies.
Using research findings from a study conducted with oncologists to explore the latest themes and trends, our experts will share feedback on some of the key opportunities and challenges, and demonstrate how some of the latest methodologies utilising ethnography, advanced analytics, behavioural science and agile techniques can deliver the insights required for success.
- Gain an understanding of some key trends in the oncology landscape
- Learn about current and future challenges and opportunities from key stakeholders
- Discover some new tools and techniques to generate the insights needed to compete in this competitive and rapidly evolving market